John McCall, PhD.
Chairman of the Board
Dr. McCall began his career as a medicinal chemist with Upjohn and subsequently held positions with Pharmacia and Upjohn, Pharmacia, and Pfizer. He was Director of CNS Research with Upjohn, Vice President and Global Head of Chemistry for both Pharmacia and Pharmacia Upjohn and Vice President Research with Pfizer. He has extensive consulting experience via his privately owned PharMac firm, advising NIH, academic, and pharmaceutical partners in the translational drug discovery and development areas. Dr. McCall’s expertise includes medicinal biochemistry, steroidal chemistry, risk minimization and strategic planning. Dr. McCall currently serves on boards and scientific advisory boards, consults, advises the Weston Foundation, and serves as VP and board chair for Reveragen BioPharma. Dr. McCall holds over 90US patents and has over 80 refereed publications.
